Although our prior studies suggest a critical role of the CRTC1-MAML2 fusion expression in the growth and survival of human MEC cells in vitro and in xenograft studies (31, 32), its role in maintaining established MEC tumors in vivo has not been validated. The gene discussed is MAML2; the disease is mucoepidermoid carcinoma.